TOP TIERMARKET NEWSWIRE
News & sentiment

AKEBIA THERAPEUTICS (AKBA) — News & AI sentiment

AKEBIA THERAPEUTICS (AKBA) news roundup. 1 story in the last 24 hours, 1 in the past week, 7 over 30 days. Average 24-hour sentiment is 50/100 — neutral (50 is neutral). Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 1 sales totalling $62K — net selling of $62K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
1
avg sentiment 50/100
7d stories
1
avg sentiment 50/100
30d stories
7
avg sentiment 55.6/100
Insider net (90d)
$62K
0 buys · 1 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on AKBA

20h ago
Jul 14
Jul 2
Jun 30
Jun 30
Jun 30
Jun 30
Jun 22
Jun 10
Jun 1
May 28
May 20
May 7
Open AKBA in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →